https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-rytelo
Drug Trials Snapshots: RYTELO | FDA
RYTELO is a prescription medicine used to treat a condition called low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults with anemia.
drug trials snapshotsrytelofda
https://pmc.ncbi.nlm.nih.gov/articles/PMC11623864/
Imetelstat (Rytelo): a promising treatment for adults with lower-risk MDS and transfusion-dependent...